Guangdong Provincial People's Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1946-01-01

Employees: -

Market Cap: -

Website: http://www.gdghospital.org.cn

Clinical Trials

Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer

Phase 2

Completed

Conditions: Triple-Negative Breast Cancer

Interventions: Drug: Apatinib

First Posted Date: 2017-08-09

Last Posted Date: 2022-02-02

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 31

Registration Number: NCT03243838

Locations: 🇨🇳
Guangdong general hospital, Guangzhou, Guangdong, China
🇨🇳
Guangdong General Hospital, Guangzhou, China

Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Phase 4

Conditions: IgA Nephropathy

Interventions: Drug: prednisone and cyclophosphamide
Drug: prednisone alone

First Posted Date: 2017-07-17

Last Posted Date: 2017-07-17

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 133

Registration Number: NCT03218852

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Conditions: Fasting Plasma Glucose
All-cause Mortality
Ischemic Heart Failure
Lipids
Cardiovascular Outcomes

First Posted Date: 2017-07-02

Last Posted Date: 2017-07-02

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 2000

Registration Number: NCT03206593

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy

Phase 4

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: Mycophenolate Mofetil
Drug: Cyclosporins

First Posted Date: 2017-05-31

Last Posted Date: 2019-03-18

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 128

Registration Number: NCT03170323

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein

Phase 4

Completed

Conditions: Chronic Kidney Diseases

Interventions: Drug: Amiloride
Drug: Hydrochlorothiazide

First Posted Date: 2017-05-31

Last Posted Date: 2020-09-18

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 40

Registration Number: NCT03170336

Locations: 🇨🇳
Nephrology Dept,Guangdong General Hospital, Guangzhou, Guangdong, China

Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-up

Conditions: Myocardial Infarction
Chronic Kidney Diseases
Cerebral Infarction
Mortality

First Posted Date: 2017-05-25

Last Posted Date: 2017-05-25

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 30000

Registration Number: NCT03166696

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
🇨🇳
the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳
Yue Bei People's Hospital, Shaoguan, Guangdong, China

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Not Applicable

Completed

Conditions: Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Interventions: Other: Baduanjin exercise

First Posted Date: 2017-05-22

Last Posted Date: 2020-07-29

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 86

Registration Number: NCT03162133

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Phase 2

Completed

Conditions: Triple-Negative Breast Cancer

Interventions: Drug: DCb (docetaxel/carboplatin) versus EC followed by D (epirubicin/cyclophosphamide followed by docetaxe)

First Posted Date: 2017-05-16

Last Posted Date: 2022-09-01

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 93

Registration Number: NCT03154749

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer

Phase 2

Completed

Conditions: HER2-Positive Breast Cancer

Interventions: Drug: TCH (docetaxel/carboplatin/trastuzumab) versus EC-TH(epirubicin/cyclophosphamide followed by docetaxe plus trastuzumab)

First Posted Date: 2017-05-04

Last Posted Date: 2020-07-28

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 140

Registration Number: NCT03140553

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ticagrelor

First Posted Date: 2017-03-27

Last Posted Date: 2017-03-27

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 51

Registration Number: NCT03092076

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy